LITHIUM 4,6-DICHLOROPYRIDAZINE-3-CARBOXYLATE
UNII 7T8F66B4WA

Substance Identification & Data

This profile provides standardized clinical and technical data for Lithium 4,6-dichloropyridazine-3-carboxylate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 7T8F66B4WA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2245238-80-4 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

7T8F66B4WA

CAS Registry Number

2245238-80-4

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LITHIUM 4,6-DICHLOROPYRIDAZINE-3-CARBOXYLATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C5HCl2N2O2.Li

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

DAHURLFXBYFSFD-UHFFFAOYSA-M

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

154640671

Unique identification number in the NCBI database of chemical substances.

Substance Type

Lithium 4,6-dichloropyridazine-3-carboxylate

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[O-]C(=O)c1nnc(Cl)cc1Cl.[Li+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lithium 4,6-dichloropyridazine-3-carboxylate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.